期刊
GENE THERAPY
卷 19, 期 4, 页码 365-374出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2011.104
关键词
T-cell receptors; peptide/MHC; retroviral transduction; adoptive T-cell therapy
类别
资金
- NIH [GM55767, CA097296, CA033084, CA18029]
- James S McDonnell Foundation
- Leukemia and Lymphoma Society [7040]
- DFG
- Samuel and Ruth Engelberg/Irvington Institute of Cancer Research Institute
Transduction of exogenous T-cell receptor (TCR) genes into patients' activated peripheral blood T cells is a potent strategy to generate large numbers of specific T cells for adoptive therapy of cancer and viral diseases. However, the remarkable clinical promise of this powerful approach is still being overshadowed by a serious potential consequence: mispairing of the exogenous TCR chains with endogenous TCR chains. These 'mixed' heterodimers can generate new specificities that result in graft-versus-host reactions. Engineering TCR constant regions of the exogenous chains with a cysteine promotes proper pairing and reduces the mispairing, but, as we show here, does not eliminate the formation of mixed heterodimers. By contrast, deletion of the constant regions, through use of a stabilized V alpha/V beta single-chain TCR (scTv), avoided mispairing completely. By linking a high-affinity scTv to intracellular signaling domains, such as Lck and CD28, the scTv was capable of activating functional T-cell responses in the absence of either the CD3 subunits or the co-receptors, and circumvented mispairing with endogenous TCRs. Such transduced T cells can respond to the targeted antigen independent of CD3 subunits via the introduced scTv, without the transduced T cells acquiring any new undefined and potentially dangerous specificities. Gene Therapy (2012) 19, 365-374; doi: 10.1038/gt.2011.104; published online 14 July 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据